KR100604510B1 - 분석 시험 장치 및 방법 - Google Patents
분석 시험 장치 및 방법 Download PDFInfo
- Publication number
- KR100604510B1 KR100604510B1 KR1020017001614A KR20017001614A KR100604510B1 KR 100604510 B1 KR100604510 B1 KR 100604510B1 KR 1020017001614 A KR1020017001614 A KR 1020017001614A KR 20017001614 A KR20017001614 A KR 20017001614A KR 100604510 B1 KR100604510 B1 KR 100604510B1
- Authority
- KR
- South Korea
- Prior art keywords
- sample
- channel
- analyte
- capture
- reagent
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title claims description 86
- 238000000034 method Methods 0.000 title claims description 58
- 238000003556 assay Methods 0.000 claims abstract description 81
- 238000012360 testing method Methods 0.000 claims abstract description 79
- 210000004369 blood Anatomy 0.000 claims abstract description 72
- 239000008280 blood Substances 0.000 claims abstract description 72
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 53
- 239000007788 liquid Substances 0.000 claims abstract description 32
- 230000037361 pathway Effects 0.000 claims abstract description 30
- 239000000523 sample Substances 0.000 claims description 517
- 239000012528 membrane Substances 0.000 claims description 200
- 238000012546 transfer Methods 0.000 claims description 130
- 239000012530 fluid Substances 0.000 claims description 129
- 239000012491 analyte Substances 0.000 claims description 111
- 238000006243 chemical reaction Methods 0.000 claims description 75
- 239000003153 chemical reaction reagent Substances 0.000 claims description 75
- 239000000376 reactant Substances 0.000 claims description 72
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 68
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 61
- 210000002381 plasma Anatomy 0.000 claims description 54
- 239000010931 gold Substances 0.000 claims description 52
- 229910052737 gold Inorganic materials 0.000 claims description 52
- 239000000427 antigen Substances 0.000 claims description 49
- 102000036639 antigens Human genes 0.000 claims description 48
- 108091007433 antigens Proteins 0.000 claims description 48
- 108010062374 Myoglobin Proteins 0.000 claims description 42
- 102000036675 Myoglobin Human genes 0.000 claims description 42
- 238000004891 communication Methods 0.000 claims description 41
- 239000000020 Nitrocellulose Substances 0.000 claims description 35
- 229920001220 nitrocellulos Polymers 0.000 claims description 35
- 102000013394 Troponin I Human genes 0.000 claims description 34
- 108010065729 Troponin I Proteins 0.000 claims description 34
- 230000009471 action Effects 0.000 claims description 34
- 229960002685 biotin Drugs 0.000 claims description 34
- 235000020958 biotin Nutrition 0.000 claims description 34
- 239000011616 biotin Substances 0.000 claims description 34
- 108010090804 Streptavidin Proteins 0.000 claims description 28
- 102000004987 Troponin T Human genes 0.000 claims description 27
- 108090001108 Troponin T Proteins 0.000 claims description 27
- 230000000747 cardiac effect Effects 0.000 claims description 19
- 210000002966 serum Anatomy 0.000 claims description 19
- 108090001008 Avidin Proteins 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 238000002372 labelling Methods 0.000 claims description 13
- 239000011230 binding agent Substances 0.000 claims description 11
- 239000012472 biological sample Substances 0.000 claims description 11
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- -1 CK-MB Proteins 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 7
- 102000004420 Creatine Kinase Human genes 0.000 claims description 6
- 108010042126 Creatine kinase Proteins 0.000 claims description 6
- 230000019612 pigmentation Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 230000002107 myocardial effect Effects 0.000 claims description 2
- 230000000717 retained effect Effects 0.000 claims description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 5
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 5
- 102000009151 Luteinizing Hormone Human genes 0.000 claims 5
- 108010073521 Luteinizing Hormone Proteins 0.000 claims 5
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims 5
- 229940040129 luteinizing hormone Drugs 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000012284 sample analysis method Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 13
- 238000000746 purification Methods 0.000 abstract 1
- 108091006146 Channels Proteins 0.000 description 457
- 239000010410 layer Substances 0.000 description 157
- 239000000463 material Substances 0.000 description 58
- 239000000243 solution Substances 0.000 description 32
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 31
- 238000001514 detection method Methods 0.000 description 25
- 239000000126 substance Substances 0.000 description 25
- 230000008901 benefit Effects 0.000 description 24
- 238000003018 immunoassay Methods 0.000 description 20
- 239000011324 bead Substances 0.000 description 17
- 239000002245 particle Substances 0.000 description 16
- 239000011148 porous material Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 238000010276 construction Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000049 pigment Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 239000008279 sol Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 238000011049 filling Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 102000001708 Protein Isoforms Human genes 0.000 description 6
- 108010029485 Protein Isoforms Proteins 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 102000016349 Myosin Light Chains Human genes 0.000 description 5
- 108010067385 Myosin Light Chains Proteins 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000037029 cross reaction Effects 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 4
- 102000013534 Troponin C Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000005875 antibody response Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 210000005003 heart tissue Anatomy 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 206010013654 Drug abuse Diseases 0.000 description 3
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 3
- 102000007390 Glycogen Phosphorylase Human genes 0.000 description 3
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 239000013060 biological fluid Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 108091022862 fatty acid binding Proteins 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 208000023589 ischemic disease Diseases 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 230000016087 ovulation Effects 0.000 description 3
- 229920006267 polyester film Polymers 0.000 description 3
- 238000011533 pre-incubation Methods 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 150000003378 silver Chemical class 0.000 description 3
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 3
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 3
- 208000011117 substance-related disease Diseases 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 102000004903 Troponin Human genes 0.000 description 2
- 108090001027 Troponin Proteins 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000007824 enzymatic assay Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 108010046301 glucose peroxidase Proteins 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000393496 Electra Species 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710171736 Myoglobin-1 Proteins 0.000 description 1
- 101710171737 Myoglobin-2 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012070 reactive reagent Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
- G01N33/54389—Immunochromatographic test strips based on lateral flow with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/805—Haemoglobins; Myoglobins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9123—Phosphotransferases in general with a nitrogenous group as acceptor (2.7.3), e.g. histidine kinases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of Radiation (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/130,164 | 1998-08-06 | ||
| US09/130,164 US6171870B1 (en) | 1998-08-06 | 1998-08-06 | Analytical test device and method for use in medical diagnoses |
| US09/353,188 | 1999-07-14 | ||
| US09/353,190 | 1999-07-14 | ||
| US09/353,190 US6214629B1 (en) | 1998-08-06 | 1999-07-14 | Analytical test device and method for use in medical diagnoses |
| US09/353,188 US6410341B1 (en) | 1998-08-06 | 1999-07-14 | Analytical test device and method for use in medical diagnoses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20010085338A KR20010085338A (ko) | 2001-09-07 |
| KR100604510B1 true KR100604510B1 (ko) | 2006-07-25 |
Family
ID=27383975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020017001614A KR100604510B1 (ko) | 1998-08-06 | 1999-08-06 | 분석 시험 장치 및 방법 |
Country Status (12)
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673562B2 (en) * | 2000-08-24 | 2004-01-06 | Spectral Diagnostics, Inc. | Differential immunoassay |
| EP1947459A3 (en) * | 2000-08-24 | 2008-09-24 | Nanogen, Inc. | Differential immunoassay |
| SE0003662D0 (sv) * | 2000-10-11 | 2000-10-11 | Pharmacia Diagnostics Ab | Assay method and kit therefor |
| WO2002052263A1 (en) * | 2000-12-22 | 2002-07-04 | Bio A.R.T. Bvba | Flow through assay device, diagnostic kit comprising said assay device and use of said assay device in the detection of an analyte present in a sample |
| DE60218695T2 (de) * | 2001-08-09 | 2007-11-15 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensoren und messverfahren |
| CA2488933C (en) * | 2002-04-23 | 2016-11-01 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
| US7611670B2 (en) * | 2002-04-23 | 2009-11-03 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
| US7279134B2 (en) * | 2002-09-17 | 2007-10-09 | Intel Corporation | Microfluidic devices with porous membranes for molecular sieving, metering, and separations |
| US7256053B2 (en) | 2002-10-24 | 2007-08-14 | Nanogen, Inc. | Diagnostic device for analyte detection |
| AU2003278040A1 (en) * | 2002-10-24 | 2004-05-13 | Spectral Diagnostics Inc. | Diagnostic device |
| EP1664781B1 (en) * | 2003-09-22 | 2013-05-08 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
| WO2005095967A1 (en) * | 2004-03-23 | 2005-10-13 | Quidel Corporation | Hybrid phase lateral flow assay |
| US20060078471A1 (en) * | 2004-10-12 | 2006-04-13 | Witty Thomas R | Apparatus and method for a precision flow assay |
| WO2006098804A2 (en) * | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7189522B2 (en) * | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7794656B2 (en) * | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
| US7871568B2 (en) * | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
| US20120003727A1 (en) * | 2006-03-10 | 2012-01-05 | Javanbakhsh Esfandiari | Immunoassay Device for Detecting Antibodies and Antigens |
| US20080115798A1 (en) * | 2006-06-08 | 2008-05-22 | Donald Frank Rainey | Ultra-size cosmetic applicator having enhanced surface area |
| US8008034B2 (en) * | 2006-10-13 | 2011-08-30 | Theranos, Inc. | Reducing optical interference in a fluidic device |
| US20090042737A1 (en) * | 2007-08-09 | 2009-02-12 | Katz Andrew S | Methods and Devices for Correlated, Multi-Parameter Single Cell Measurements and Recovery of Remnant Biological Material |
| CN103226150B (zh) * | 2007-10-30 | 2015-01-21 | 松下健康医疗器械株式会社 | 分析用仪器和使用该分析用仪器的分析装置及分析方法 |
| US20110287461A1 (en) * | 2008-05-27 | 2011-11-24 | Zbx Corporation | Enzymatic analytical membrane, test device and method |
| US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
| WO2010022537A1 (zh) * | 2008-08-26 | 2010-03-04 | 红电医学科技股份有限公司 | 流体检测试片的基板 |
| US20110318822A1 (en) * | 2008-08-29 | 2011-12-29 | Chih-Wei Hsieh | Analytical strip |
| JP5243609B2 (ja) * | 2008-09-16 | 2013-07-24 | 紅電醫學科技股▲分▼有限公司 | 組み合わせ式テストストリップ |
| TWI402500B (zh) * | 2008-09-19 | 2013-07-21 | Actherm Inc | 流體檢測試片 |
| JP5162031B2 (ja) | 2008-10-09 | 2013-03-13 | 紅電醫學科技股▲分▼有限公司 | 液体の検査方法 |
| AU2008362976B2 (en) | 2008-10-17 | 2013-03-28 | Actherm Inc. | Liquid test strip and the method |
| JP2012505417A (ja) | 2008-10-17 | 2012-03-01 | 紅電醫學科技股▲分▼有限公司 | 体液試験ストリップ及びその方法 |
| US9720003B2 (en) | 2008-12-22 | 2017-08-01 | Koninklijke Philips Electronics N.V. | Assay for Troponin I using magnetic labels |
| US10203310B2 (en) | 2009-01-26 | 2019-02-12 | Detectachem Llc | Chemical detection of substances by utilizing a sample medium impregnated with solid test chemicals |
| US8453525B2 (en) * | 2009-02-09 | 2013-06-04 | Healthpoint Diagnostix, Inc. | Plasma sample collection device |
| WO2010102294A1 (en) * | 2009-03-06 | 2010-09-10 | President And Fellows Of Harvard College | Methods of micropatterning paper-based microfluidics |
| KR101329846B1 (ko) * | 2009-03-23 | 2013-11-14 | 액텀 아이엔씨. | 분석 스트립 및 그의 제조 방법 |
| CN102313802B (zh) * | 2010-07-09 | 2014-04-23 | 上海荣盛生物药业有限公司 | 检测抗原或抗体的组件及其用途 |
| WO2012011074A2 (en) | 2010-07-22 | 2012-01-26 | Hach Company | Lab-on-a-chip for alkalinity analysis |
| JP5650970B2 (ja) * | 2010-09-28 | 2015-01-07 | 富士フイルム株式会社 | 検査装置およびその制御方法、並びに検査用反応容器 |
| US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
| CN103917643B (zh) | 2011-11-22 | 2020-06-05 | 西门子医疗保健诊断公司 | 包含用于复原为校准和/或质量控制溶液的干燥试剂的设备，及其生产和使用方法 |
| KR101280054B1 (ko) * | 2012-05-31 | 2013-06-28 | 에스디 바이오센서 주식회사 | 현장진단 면역크로마토그래피용 동결건조 접합체 구조물, 이를 이용하는 면역분석용 키트 및 상기 키트를 이용하는 분석방법 |
| US9180449B2 (en) | 2012-06-12 | 2015-11-10 | Hach Company | Mobile water analysis |
| WO2014081460A1 (en) * | 2012-11-20 | 2014-05-30 | Kisner Mark | Chemical sequencing and control to expand and enhance detection capabilities utilizing a colorimetric test |
| USD768872S1 (en) | 2012-12-12 | 2016-10-11 | Hach Company | Cuvette for a water analysis instrument |
| US9482675B1 (en) * | 2013-07-31 | 2016-11-01 | University Of Kentucky Research Foundation | Methods and systems for prognosis and diagnosis of brain damage |
| SG11201608278WA (en) | 2014-04-02 | 2016-10-28 | Chembio Diagnostic Systems Inc | Immunoassay utilizing trapping conjugate |
| US10258984B2 (en) * | 2014-06-16 | 2019-04-16 | Koninklijke Philips N.V. | Cartridge for fast sample intake |
| US9885699B2 (en) * | 2014-07-31 | 2018-02-06 | Becton, Dickinson And Company | Methods for processing whole blood samples, and compositions for use in practicing the same |
| US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
| US9981264B2 (en) | 2014-11-04 | 2018-05-29 | Grace Bio-Labs, Inc. | Nitrocellulose extrusion for porous film strips |
| JP2018506718A (ja) | 2015-01-30 | 2018-03-08 | ヒューレット−パッカード デベロップメント カンパニー エル．ピー．Ｈｅｗｌｅｔｔ‐Ｐａｃｋａｒｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏｍｐａｎｙ， Ｌ．Ｐ． | 診断装置 |
| US10725031B1 (en) | 2017-04-26 | 2020-07-28 | Conquerab Inc. | Reflux device for detection of analytes in samples |
| CN107389911A (zh) * | 2017-07-12 | 2017-11-24 | 柳州康云互联科技有限公司 | 用于移动端的快速分离检测传感器 |
| AU2019284882A1 (en) * | 2018-06-12 | 2021-01-07 | Nowdiagnostics, Inc. | Device and method for collecting plasma |
| US11766369B1 (en) | 2020-09-30 | 2023-09-26 | Douglas Dillon | Single use protective cover for patient transport device |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3029579C2 (de) | 1980-08-05 | 1985-12-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut |
| US4987065A (en) | 1983-07-05 | 1991-01-22 | Enzo Biochem, Inc. | In vivo labelling of polynucleotide sequences |
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| US4753776A (en) | 1986-10-29 | 1988-06-28 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
| US5079142A (en) | 1987-01-23 | 1992-01-07 | Synbiotics Corporation | Orthogonal flow immunoassays and devices |
| US4774192A (en) | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
| CA1303983C (en) * | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
| US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| US5096809A (en) | 1988-07-25 | 1992-03-17 | Pacific Biotech, Inc. | Whole blood assays using porous membrane support devices |
| US5114890A (en) | 1988-09-02 | 1992-05-19 | Teledyne Industries, Inc. | Zirconium-containing coating composition |
| US5135716A (en) | 1989-07-12 | 1992-08-04 | Kingston Diagnostics, L.P. | Direct measurement of HDL cholesterol via dry chemistry strips |
| US5075078A (en) | 1989-10-05 | 1991-12-24 | Abbott Laboratories | Self-performing immunochromatographic device |
| US4993092A (en) | 1989-11-13 | 1991-02-19 | Weeks David B | Patient carrier cover and method |
| US5110724A (en) | 1990-04-02 | 1992-05-05 | Cholestech Corporation | Multi-analyte assay device |
| US5843691A (en) * | 1993-05-15 | 1998-12-01 | Lifescan, Inc. | Visually-readable reagent test strip |
| US6171870B1 (en) * | 1998-08-06 | 2001-01-09 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
-
1999
- 1999-08-06 CN CNB998110566A patent/CN1145027C/zh not_active Expired - Fee Related
- 1999-08-06 AT AT99940165T patent/ATE237807T1/de not_active IP Right Cessation
- 1999-08-06 CN CNB2004100039525A patent/CN1250970C/zh not_active Expired - Fee Related
- 1999-08-06 AU AU54208/99A patent/AU764444B2/en not_active Ceased
- 1999-08-06 DE DE69906986T patent/DE69906986T2/de not_active Expired - Lifetime
- 1999-08-06 MX MXPA01001384A patent/MXPA01001384A/es active IP Right Grant
- 1999-08-06 KR KR1020017001614A patent/KR100604510B1/ko not_active IP Right Cessation
- 1999-08-06 CA CA002339599A patent/CA2339599A1/en not_active Abandoned
- 1999-08-06 WO PCT/EP1999/005712 patent/WO2000008466A2/en active IP Right Grant
- 1999-08-06 JP JP2000564049A patent/JP2002522767A/ja active Pending
- 1999-08-06 EP EP99940165A patent/EP1102989B1/en not_active Expired - Lifetime
-
2001
- 2001-02-06 US US09/777,549 patent/US6673628B2/en not_active Expired - Fee Related
- 2001-11-30 HK HK01108465A patent/HK1039518A1/xx active IP Right Revival
-
2003
- 2003-11-21 AU AU2003262455A patent/AU2003262455A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1145027C (zh) | 2004-04-07 |
| DE69906986D1 (de) | 2003-05-22 |
| WO2000008466A9 (en) | 2000-06-29 |
| JP2002522767A (ja) | 2002-07-23 |
| CA2339599A1 (en) | 2000-02-17 |
| CN1519563A (zh) | 2004-08-11 |
| WO2000008466A2 (en) | 2000-02-17 |
| WO2000008466A3 (en) | 2000-05-18 |
| EP1102989A2 (en) | 2001-05-30 |
| ATE237807T1 (de) | 2003-05-15 |
| CN1318151A (zh) | 2001-10-17 |
| DE69906986T2 (de) | 2004-02-12 |
| EP1102989B1 (en) | 2003-04-16 |
| US6673628B2 (en) | 2004-01-06 |
| HK1039518A1 (en) | 2002-04-26 |
| MXPA01001384A (es) | 2002-11-29 |
| KR20010085338A (ko) | 2001-09-07 |
| AU5420899A (en) | 2000-02-28 |
| CN1250970C (zh) | 2006-04-12 |
| AU2003262455A1 (en) | 2003-12-18 |
| US20010039059A1 (en) | 2001-11-08 |
| AU764444B2 (en) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100604510B1 (ko) | 분석 시험 장치 및 방법 | |
| US6214629B1 (en) | Analytical test device and method for use in medical diagnoses | |
| US6410341B1 (en) | Analytical test device and method for use in medical diagnoses | |
| US6171870B1 (en) | Analytical test device and method for use in medical diagnoses | |
| US11921107B2 (en) | Assay device having controllable sample size | |
| US8349618B2 (en) | Diagnostic devices | |
| KR20130085993A (ko) | 분석 장치를 통한 유체 유동의 제어 | |
| KR20130085994A (ko) | 다수의 시약 셀을 갖는 분석 장치 | |
| KR20130085991A (ko) | 코너 주위의 균일한 유동을 갖는 분석 장치 | |
| US20210263020A1 (en) | Method of Improving Liquid Sample Flow in Assay Device | |
| KR20130085995A (ko) | 증가된 감도를 갖는 저체적 분석 장치 | |
| US20060205086A1 (en) | Diagnostic device | |
| JP2572812B2 (ja) | ペースト状試料中の分析物を測定するためのテストキット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |